Lib Therapeutics
LIB Therapeutics is a privately held, late-stage biopharmaceutical company dedicated to bringing novel, safe and convenient subcutaneous and oral PCSK9 inhibitors to the millions of patients at very high and high-risk of cardiovascular disease (CVD), and the 30 million with familial hypercholesterolemia (FH), who require additional large reductions in low density lipoprotein-cholesterol (LDL-C) despite maximally tolerated statins and other lipid lowering agents.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
12
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Lib Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- SG
Shekar Ganesa
Chief Technical Officer (CTO) · Other
EmailPhone - DT
Denny Thompson
Director of Finance & Controller · Finance & Accounting
EmailPhone - EP
Erin Pirrotta
Director · General Business & Management
EmailPhone - ES
Evan Stein
COO & CSO · Other
EmailPhone
Showing 4 of 7 verified contacts
Top roles at Lib Therapeutics
4 distinct titles indexed · top 4 shown.
- 1chief technical officer (cto)
- 1coo & cso
- 1director
- 1director of finance & controller
Sign up to unlock all 7 contacts at Lib Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Lib Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.